187 related articles for article (PubMed ID: 26616111)
41. Genome-wide association study of obsessive-compulsive disorder.
Stewart SE; Yu D; Scharf JM; Neale BM; Fagerness JA; Mathews CA; Arnold PD; Evans PD; Gamazon ER; Davis LK; Osiecki L; McGrath L; Haddad S; Crane J; Hezel D; Illman C; Mayerfeld C; Konkashbaev A; Liu C; Pluzhnikov A; Tikhomirov A; Edlund CK; Rauch SL; Moessner R; Falkai P; Maier W; Ruhrmann S; Grabe HJ; Lennertz L; Wagner M; Bellodi L; Cavallini MC; Richter MA; Cook EH; Kennedy JL; Rosenberg D; Stein DJ; Hemmings SM; Lochner C; Azzam A; Chavira DA; Fournier E; Garrido H; Sheppard B; Umaña P; Murphy DL; Wendland JR; Veenstra-VanderWeele J; Denys D; Blom R; Deforce D; Van Nieuwerburgh F; Westenberg HG; Walitza S; Egberts K; Renner T; Miguel EC; Cappi C; Hounie AG; Conceição do Rosário M; Sampaio AS; Vallada H; Nicolini H; Lanzagorta N; Camarena B; Delorme R; Leboyer M; Pato CN; Pato MT; Voyiaziakis E; Heutink P; Cath DC; Posthuma D; Smit JH; Samuels J; Bienvenu OJ; Cullen B; Fyer AJ; Grados MA; Greenberg BD; McCracken JT; Riddle MA; Wang Y; Coric V; Leckman JF; Bloch M; Pittenger C; Eapen V; Black DW; Ophoff RA; Strengman E; Cusi D; Turiel M; Frau F; Macciardi F; Gibbs JR; Cookson MR; Singleton A; ; Hardy J; ; Crenshaw AT; Parkin MA; Mirel DB; Conti DV; Purcell S; Nestadt G; Hanna GL; Jenike MA; Knowles JA; Cox N; Pauls DL
Mol Psychiatry; 2013 Jul; 18(7):788-98. PubMed ID: 22889921
[TBL] [Abstract][Full Text] [Related]
42. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
[TBL] [Abstract][Full Text] [Related]
43. Imaging genetics in obsessive-compulsive disorder: linking genetic variations to alterations in neuroimaging.
Grünblatt E; Hauser TU; Walitza S
Prog Neurobiol; 2014 Oct; 121():114-24. PubMed ID: 25046835
[TBL] [Abstract][Full Text] [Related]
44. Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway.
Walitza S; Wewetzer C; Gerlach M; Klampfl K; Geller F; Barth N; Hahn F; Herpertz-Dahlmann B; Gössler M; Fleischhaker C; Schulz E; Hebebrand J; Warnke A; Hinney A
J Neural Transm (Vienna); 2004 Jul; 111(7):817-25. PubMed ID: 15206000
[TBL] [Abstract][Full Text] [Related]
45. Gender in obsessive-compulsive disorder: clinical and genetic findings.
Lochner C; Hemmings SM; Kinnear CJ; Moolman-Smook JC; Corfield VA; Knowles JA; Niehaus DJ; Stein DJ
Eur Neuropsychopharmacol; 2004 Mar; 14(2):105-13. PubMed ID: 15013025
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms within the neuronal cadherin (CDH2) gene are associated with obsessive-compulsive disorder (OCD) in a South African cohort.
McGregor NW; Lochner C; Stein DJ; Hemmings SM
Metab Brain Dis; 2016 Feb; 31(1):191-6. PubMed ID: 26093892
[TBL] [Abstract][Full Text] [Related]
47. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
Dickel DE; Veenstra-VanderWeele J; Cox NJ; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867
[TBL] [Abstract][Full Text] [Related]
48. Genetic neuropathology of obsessive psychiatric syndromes.
Jaffe AE; Deep-Soboslay A; Tao R; Hauptman DT; Kaye WH; Arango V; Weinberger DR; Hyde TM; Kleinman JE
Transl Psychiatry; 2014 Sep; 4(9):e432. PubMed ID: 25180571
[TBL] [Abstract][Full Text] [Related]
49. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder.
Erdal ME; Tot S; Yazici K; Yazici A; Herken H; Erdem P; Derici E; Camdeviren H
Depress Anxiety; 2003; 18(1):41-5. PubMed ID: 12900951
[TBL] [Abstract][Full Text] [Related]
50. Identifying risk loci for obsessive-compulsive disorder and shared genetic component with schizophrenia: A large-scale multi-trait association analysis with summary statistics.
Dai J; Chen K; Zhu Y; Xia L; Wang T; Yuan Z; Zeng P
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110906. PubMed ID: 38043635
[TBL] [Abstract][Full Text] [Related]
51. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder.
Katerberg H; Cath DC; Denys DA; Heutink P; Polman A; van Nieuwerburgh FC; Deforce DL; Bochdanovits Z; van Balkom AJ; den Boer JA
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):167-76. PubMed ID: 19521967
[TBL] [Abstract][Full Text] [Related]
52. The genetic studies of obsessive-compulsive disorder and its future directions.
Kim SJ; Kim CH
Yonsei Med J; 2006 Aug; 47(4):443-54. PubMed ID: 16941732
[TBL] [Abstract][Full Text] [Related]
53. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.
Karayiorgou M; Sobin C; Blundell ML; Galke BL; Malinova L; Goldberg P; Ott J; Gogos JA
Biol Psychiatry; 1999 May; 45(9):1178-89. PubMed ID: 10331110
[TBL] [Abstract][Full Text] [Related]
54. Genetics of obsessive-compulsive disorder.
Mahjani B; Bey K; Boberg J; Burton C
Psychol Med; 2021 Oct; 51(13):2247-2259. PubMed ID: 34030745
[TBL] [Abstract][Full Text] [Related]
55. Population-based, multigenerational family clustering study of obsessive-compulsive disorder.
Mataix-Cols D; Boman M; Monzani B; Rück C; Serlachius E; Långström N; Lichtenstein P
JAMA Psychiatry; 2013 Jul; 70(7):709-17. PubMed ID: 23699935
[TBL] [Abstract][Full Text] [Related]
56. 5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option.
Lennertz L; Wagner M; Grabe HJ; Franke PE; Guttenthaler V; Rampacher F; Schulze-Rauschenbach S; Vogeley A; Benninghoff J; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Mössner R
Eur Neuropsychopharmacol; 2014 Jan; 24(1):86-94. PubMed ID: 23928294
[TBL] [Abstract][Full Text] [Related]
57. Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder.
Márquez L; Camarena B; Hernández S; Lóyzaga C; Vargas L; Nicolini H
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1600-5. PubMed ID: 23999029
[TBL] [Abstract][Full Text] [Related]
58. No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population.
Umehara H; Numata S; Tajima A; Kinoshita M; Nakaaki S; Imoto I; Sumitani S; Ohmori T
Hum Psychopharmacol; 2015 Sep; 30(5):372-6. PubMed ID: 26010653
[TBL] [Abstract][Full Text] [Related]
59. Serotonin transporter promoter polymorphism is associated with executive function impairments in patients with obsessive compulsive disorder.
Tükel R; Alkaş E; Gürvit H; Aslantaş Ertekin B; Ertekin E; Baran B; Akça Kalem Ş; Saruhan Direskeneli G
Clin Neuropsychol; 2016 May; 30(4):536-46. PubMed ID: 26986829
[TBL] [Abstract][Full Text] [Related]
60. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.
Meira-Lima I; Shavitt RG; Miguita K; Ikenaga E; Miguel EC; Vallada H
Genes Brain Behav; 2004 Apr; 3(2):75-9. PubMed ID: 15005715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
